Neurocrine Bio. (NBIX) PT Lowered to $137 at UBS
Tweet Send to a Friend
(Updated - April 4, 2025 10:40 AM EDT)
UBS analyst Ashwani Verma lowered the price target on Neurocrine Bio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Ashwani Verma lowered the price target on Neurocrine Bio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
